Prosecution Insights
Last updated: October 02, 2026
Application No. 18/038,434

ELECTRICAL STIMULATION THERAPY

Non-Final OA §102§103
Filed
May 23, 2023
Priority
Dec 23, 2020 — provisional 63/130,086 +2 more
Examiner
HULBERT, AMANDA K
Art Unit
3792
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Medtronic Inc.
OA Round
1 (Non-Final)
85%
Grant Probability
Favorable
1-2
OA Rounds
0m
Est. Remaining
89%
With Interview

Examiner Intelligence

Grants 85% — above average
85%
Career Allowance Rate
652 granted / 771 resolved
+14.6% vs TC avg
Minimal +4% lift
Without
With
+4.2%
Interview Lift
resolved cases with interview
Typical timeline
3y 1m
Avg Prosecution
22 currently pending
Career history
803
Total Applications
across all art units

Statute-Specific Performance

§101
4.1%
-35.9% vs TC avg
§103
42.3%
+2.3% vs TC avg
§102
24.8%
-15.2% vs TC avg
§112
22.8%
-17.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 771 resolved cases

Office Action

§102 §103
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1-4, 7-16, and 19-20 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Dinsmoor (US 2019/0388692). Regarding claims 1, 16, and 20, Dinsmoor discloses the claimed apparatus and related method including (e.g. [0053], [0054], [0060], [0061], [0074] - [0081], figures 2A, 3, 4B-7) sensing circuitry (e.g. sensing circuitry 212); a stimulation generator (e.g. stimulation generator 211); and processing circuitry (e.g. processing circuitry 214), the processing circuitry configured to: control the stimulation generator to deliver a pulse train to a patient, the pulse train comprising at least one first pulse at least partially interleaved with at least one second pulse (e.g. interleaved pulses as shown in Figures 4B-6); deliver a pulse train to a patient, the pulse train comprising at least one first pulse at least partially interleaved with at least one second pulse, wherein the at least one first pulse includes a cathodic active first phase and a passive second phase, and wherein the at least one second pulse includes an anodic first phase and passive second phase, (e.g. interleaved pulses as shown in fig. 4B, [0108]-[0110] which shows that the 1st pulses (control pulses 412A-N) are biphasic with negative and positive phases, an interphase interval and a passive recharge portion (see [0053]). The 2nd pulses (informed pulses 424A- N) are interleaved with the 1st pulses and are biphasic with positive and negative phases and an interphase interval ([0110]). The negative (anodic) phase can be before or after the positive (cathodic) phase ([0108])); sense, via the sensing circuitry, an electrical signal elicited by electrical stimulation delivered to the patient from the stimulation generator (e.g. sensing as disclosed in [0060]-[0061]); Regarding claim 2, Dinsmoor additionally discloses wherein the at least one first pulse comprises a plurality of first pulses and the at least one second pulse comprises a plurality of second pulses (e.g. as shown in Figures 4B-6). Regarding claim 3, Dinsmoor additionally discloses wherein respective first pulses of the plurality of first pulses are interleaved with respective second pulses of the plurality of second pulses on a one to one pulse basis (e.g. as shown in Figures 4B-6). Regarding claim 4, Dinsmoor additionally discloses wherein the plurality of first pulses have the same amplitude as the plurality of second pulses (e.g. as shown in Figure 5). Regarding claim 7, Dinsmoor additionally discloses wherein the at least one first pulse is delivered by a first combination of electrodes and the at least one second pulse is delivered by a second combination of electrodes (e.g. different electrode combinations as disclosed in [0053]). Regarding claim 8, Dinsmoor additionally discloses wherein the first combination of electrodes and the second combination of electrodes have at least one common electrode (e.g. different electrode combinations as disclosed in [0053]). Regarding claim 9, Dinsmoor additionally discloses wherein the first combination of electrodes is different than the second combination of electrodes (e.g. different electrode combinations as disclosed in [0053]). Regarding claims 10 and 19, Dinsmoor additionally discloses wherein the processing circuitry is configured to: control the stimulation generator to deliver a pulse train at a frequency to a patient, the pulse train comprising a plurality of third pulses at least partially interleaved with a plurality of fourth pulses; and sense the electrical signal elicited by a respective third pulse of the plurality of third pulses, wherein the plurality of third pulses are configured to facilitate sensing elicited electrical signals, each pulse of the plurality of third pulses having an active first phase and active second phase, and wherein each pulse of the plurality of fourth pulses comprises an active first phase and a passive second phase (e.g. extra pulses that are interleaved as shown in Figures 5 and 6). Regarding claim 11, Dinsmoor additionally discloses, wherein the processing circuitry is configured to control the stimulation generator to deliver the plurality of third pulses and the plurality of fourth pulses such that at least one pulse of the plurality of fourth pulses has an interphase interval that is longer than an interphase interval of at least one pulse of the plurality of third pulses (e.g. as shown in Figures 5 and 6). Regarding claim 12, Dinsmoor additionally discloses wherein the processing circuitry is configured to control the stimulation generator to deliver the plurality of third pulses and the plurality of fourth pulses such that the active first phase of at least one pulse of the plurality of fourth pulses has a lower amplitude than the active first phases of at least one pulse of the plurality of third pulses (e.g. as shown in Figures 5 and 6). Regarding claim 13, Dinsmoor additionally discloses wherein the processing circuitry is configured to sense an evoked compound action potential (ECAP) evoked by each pulse of the plurality of third pulses instead of sensing an ECAP evoked by each pulse of the plurality of fourth pulses (e.g. decrease frequency of ECAP sensing as shown in [0074]). Regarding claim 14, Dinsmoor additionally discloses wherein the frequency of the pulse train comprises a first frequency, the method further comprising sensing an evoked compound action potential (ECAP) at a second frequency less than that of the first frequency (e.g. decrease frequency of ECAP sensing as shown in [0074]). Regarding claim 15, Dinsmoor additionally discloses wherein the processing circuitry is configured to control the stimulation generator to deliver the plurality of third pulses and the plurality of fourth pulses such that the active first phase of the plurality of fourth pulses comprises a cathodic phase and the passive second phase comprises an anodic phase (e.g. the negative (anodic) phase can be before or after the positive (cathodic) phase as disclosed in [0108]). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 5-6 and 17-18 are rejected under 35 U.S.C. 103 as being unpatentable over Dinsmoor in view of Hou et. al (US 2018/0126169) Regarding claims 5-6 and 17-18, Dinsmoor discloses the claimed invention except the express mention of the use of a sensed trend or a trend line in determination of stimulation. Hou discloses that it was known in the art of measurement of ECAPs to include the use of sensed trends to determine stimulation protocol (e.g. use of trends as disclosed in [0005] – [0007] and [0057]). It would have been obvious to one having ordinary skill in the art to include the trends of Hou in the device of Dinsmoor since such a modification would provide the system with the predictable results of a reliable means of sensing and stimulating. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to Amanda K Hulbert whose telephone number is (571)270-1912. The examiner can normally be reached Monday - Friday 9:00-5:00. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Unsu Jung can be reached at 571-272-8506. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /Amanda K Hulbert/ Primary Examiner, Art Unit 3792
Read full office action

Prosecution Timeline

May 23, 2023
Application Filed
Sep 16, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12733873
TECHNIQUES FOR MIGRAINE DETECTION USING A WEARABLE DEVICE
2y 5m to grant Granted Sep 15, 2026
Patent 12727808
METHOD AND SYSTEM TO MANAGE ADAPTIVE SENSING
3y 11m to grant Granted Sep 08, 2026
Patent 12714858
MEDICAL DEVICE FOR CLOSED LOOP VAGAL NERVE STIMULATION
3y 1m to grant Granted Aug 25, 2026
Patent 12691280
CURRENT STEERING TO ACHIEVE SPATIAL SELECTIVITY FOR HIS BUNDLE PACING
4y 2m to grant Granted Jul 28, 2026
Patent 12691289
IMPLANTABLE MEDICAL DEVICE, IMPLANT COMMUNICATION SYSTEM AND METHOD FOR TRANSFERRING DATA
2y 8m to grant Granted Jul 28, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
85%
Grant Probability
89%
With Interview (+4.2%)
3y 1m (~0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 771 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month